A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal
- 26 November 1996
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 93 (24), 13565-13570
- https://doi.org/10.1073/pnas.93.24.13565
Abstract
Adenoviruses are attractive vectors for the delivery of foreign genes into mammalian cells for gene therapy. However, current vectors retain many viral genes that, when expressed at low levels, contribute to the induction of a host immune response against transduced cells. We have developed a helper-dependent packaging system for production of vectors that have large regions of the genome deleted. Helper viruses were constructed with packaging signals flanked by loxP sites so that in 293 cells that stably express the Cre recombinase (293Cre), the packaging signal was efficiently excised, rendering the helper virus genome unpackageable. However, the helper virus DNA was replicated at normal levels and could thus express all of the functions necessary in trans for replication and packaging of a vector genome containing the appropriate cis-acting elements. Serial passage of the vector in helper virus-infected 293Cre cells resulted in an ≈10-fold increase in vector titer per passage. The vector could be partially separated from residual helper virus by cesium chloride buoyant density centrifugation. Large scale preparations of vector yielded semi-purified stocks of ≈1010 transducing virions/ml, with <0.01% contamination by the E1-deleted helper virus. This system should have great utility for the generation of adenovirus-based vectors with increased cloning capacity, increased safety and reduced immunogenicity.Keywords
This publication has 51 references indexed in Scilit:
- The use of adenoviral vectors for gene therapy and gene transfer in vivoCurrent Opinion in Biotechnology, 1995
- Development of Cell Lines Capable of Complementing E1, E4, and Protein IX Defective Adenovirus Type 5 MutantsHuman Gene Therapy, 1995
- Characterization of an Adenovirus Gene Transfer Vector Containing an E4 DeletionHuman Gene Therapy, 1995
- Transfer of the CFTR Gene to the Lung of Nonhuman Primates with E1-Deleted, E2a-Defective Recombinant Adenoviruses: A Preclinical Toxicology StudyHuman Gene Therapy, 1995
- Emergence of Early Region 1-Containing Replication-Competent Adenovirus in Stocks of Replication-Defective Adenovirus Recombinants (ΔE1 + ΔE3) During Multiple Passages in 293 CellsHuman Gene Therapy, 1994
- Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosisNature Genetics, 1994
- Construction of an adenovirus-SV40 recombinant producing SV40 T antigen from an adenovirus late promoterCell, 1981
- Expression of SV40 T antigen under control of adenovirus promotersCell, 1981
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977
- Detection of specific sequences among DNA fragments separated by gel electrophoresisJournal of Molecular Biology, 1975